Jennison Associates
VKTX icon

Jennison Associates’s Viking Therapeutics VKTX Stock Holding History

Jennison Associates’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-8,268
Closed -$438K – 647
2024
Q2 		$438K Buy
8,268
+978
+13% +$64.1K ﹤0.01% 554
2024
Q1 		$598K Buy
+7,290
New +$324K ﹤0.01% 550
2019
Q4 		– Sell
-463,948
Closed -$3.19M – 674
2019
Q3 		$3.19M Sell
463,948
-43,631
-9% -$324K ﹤0.01% 479
2019
Q2 		$4.21M Sell
507,579
-5,116
-1% -$43.7K ﹤0.01% 482
2019
Q1 		$5.1M Sell
512,695
-108,094
-17% -$905K 0.01% 468
2018
Q4 		$4.75M Buy
620,789
+75,389
+14% +$901K 0.01% 485
2018
Q3 		$9.5M Buy
+545,400
New +$6.49M 0.01% 474

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return